Literature DB >> 9800105

Management of rare forms of lymphoma.

E Zucca1, F Bertoni, E Roggero, F Cavalli.   

Abstract

The recent Revised European-American Classification of Lymphoma (REAL) classification system has been shown to allow easy, accurate, and reproducible identification of several clinically distinctive lymphoma subtypes. Many of these well-recognized lymphoma entities are relatively rare, as shown by a recent large survey of more than 1400 non-Hodgkin's lymphoma (NHL) cases from eight different countries. The purpose of this article is to summarize the present information known about these less common entities. Particular attention will be paid to the management problems of the following subtypes: the marginal-zone B-cell lymphomas of nodal type (or monocytoid lymphoma, comprising 1.8% of total cases in the above-mentioned series), the extranodal marginal-zone B-cell lymphomas (or mucosa-associated lymphoma tissue [MALT] lymphomas, representing 7.6% of the cases), the splenic marginal-zone B-cell lymphomas (< 1% of cases), the mantle cell lymphomas (6% of cases), and the primary mediastinal large B-cell lymphomas (2.4% of cases). Also, the main non-cutaneous peripheral T-cell lymphoma types, which including the natural killer (NK) disorders comprise less than 12% of all lymphoma cases, are discussed.

Entities:  

Mesh:

Year:  1998        PMID: 9800105     DOI: 10.1097/00001622-199809000-00002

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  2 in total

1.  Cell cycle regulators p27 and pRb in lymphomas - correlation with histology and proliferative activity.

Authors:  M Kiviniemi; I Sauroja; A Rajamäki; K Punnonen; K O Söderström; E Salminen
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

Review 2.  Deciphering splenic marginal zone lymphoma pathogenesis: the proposed role of microRNA.

Authors:  Jacob E Robinson; Christine E Cutucache
Journal:  Oncotarget       Date:  2018-07-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.